QT Imaging Holdings, Inc. (QTI) stock
QTINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31Also trades as QTIWW
$1.69−0.11 (-6.11%)
Close on Nov 17, 2026Market cap $24.74MP/E –Yield –
QT Imaging r&d expenses
Research and development expenses are spending on new products and technology.
QT Imaging's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.53M, up 60.2% year over year. For fiscal 2025 it was $3.94M, up 20.5% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.94M | +20.5% |
| FY2024 | Dec 31, 2024 | $3.27M | +119.9% |
| FY2023 | Dec 31, 2023 | $1.49M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.62M | +80.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.72M | +102.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.24M | +60.7% |
| Q3 FY2025 | Sep 30, 2025 | $938.76K | +1.5% |
| Q2 FY2025 | Jun 30, 2025 | $901.00K | -2.6% |
| Q1 FY2025 | Mar 31, 2025 | $852.00K | +32.6% |
| Q4 FY2024 | Dec 31, 2024 | $774.16K | +92.5% |
| Q3 FY2024 | Sep 30, 2024 | $925.21K | +196.7% |
| Q2 FY2024 | Jun 30, 2024 | $925.08K | +164.6% |
| Q1 FY2024 | Mar 31, 2024 | $642.55K | +52.3% |
| Q4 FY2023 | Dec 31, 2023 | $402.26K | – |
| Q3 FY2023 | Sep 30, 2023 | $311.83K | – |
| Q2 FY2023 | Jun 30, 2023 | $349.66K | – |
| Q1 FY2023 | Mar 31, 2023 | $421.89K | – |
See a number that looks wrong?